News

Researchers at the Wilmer Eye Institute have created a clear hydrogel that turns fluorescent green under blue light. This color change allows surgeons to confirm that they have removed all of the h...

Study results were recently presented at the annual meeting of the American Academy of Ophthalmology that reveal an increased risk of post cataract surgery complications for patients with a histor...

Patients who have had prior intravitreal injects may be at a higher risk of postoperative complications after cataract surgery according to study results published from researchers at the Universit...

Results from the Phase 3 OPTIMIZE-1 trial of OCS-01, a once-daily, preservative-free corticosteroid eye drop, were presented at the 2024 ASCRS Annual Meeting.

A team of international researchers at the Anglia Ruskin University took on the task of looking into using an oxysterol compound as a non-surgical option for cataracts. 

OCS-01 is the first once-daily topical, preservative-free corticosteroid. I

Despite its phenomenal outcomes in skilled hands, modern cataract surgery can be overwhelming for patients to understand.

A study recently published in the Journal of Glaucoma highlights the potential benefits of blue-light filtering IOLs in reducing cases of glaucoma post-cataract surgery.

Cataracts are caused by the breaking down of proteins in the lens of your eyes that clump together and eventually lead to vision loss if left untreated.